China Isotope & Radiation Balance Sheet Health
Financial Health criteria checks 5/6
China Isotope & Radiation has a total shareholder equity of CN¥7.1B and total debt of CN¥1.6B, which brings its debt-to-equity ratio to 23%. Its total assets and total liabilities are CN¥13.2B and CN¥6.1B respectively. China Isotope & Radiation's EBIT is CN¥749.7M making its interest coverage ratio -430.9. It has cash and short-term investments of CN¥3.1B.
Key information
23.0%
Debt to equity ratio
CN¥1.64b
Debt
| Interest coverage ratio | -430.9x |
| Cash | CN¥3.15b |
| Equity | CN¥7.14b |
| Total liabilities | CN¥6.05b |
| Total assets | CN¥13.19b |
Recent financial health updates
China Isotope & Radiation (HKG:1763) Has A Rock Solid Balance Sheet
Mar 28
China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly
Sep 30China Isotope & Radiation (HKG:1763) Could Easily Take On More Debt
Apr 11China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly
Oct 26China Isotope & Radiation (HKG:1763) Has A Pretty Healthy Balance Sheet
Apr 01Recent updates
Why We're Not Concerned About China Isotope & Radiation Corporation's (HKG:1763) Share Price
Apr 26China Isotope & Radiation (HKG:1763) Has A Rock Solid Balance Sheet
Mar 28There Are Reasons To Feel Uneasy About China Isotope & Radiation's (HKG:1763) Returns On Capital
May 13Is Now The Time To Look At Buying China Isotope & Radiation Corporation (HKG:1763)?
Feb 07China Isotope & Radiation (HKG:1763) Will Want To Turn Around Its Return Trends
Dec 20A Look At The Intrinsic Value Of China Isotope & Radiation Corporation (HKG:1763)
Oct 28China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly
Sep 30There Are Reasons To Feel Uneasy About China Isotope & Radiation's (HKG:1763) Returns On Capital
Aug 30Is There Now An Opportunity In China Isotope & Radiation Corporation (HKG:1763)?
Jun 10China Isotope & Radiation (HKG:1763) Could Easily Take On More Debt
Apr 11Is It Time To Consider Buying China Isotope & Radiation Corporation (HKG:1763)?
Dec 28China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly
Oct 26Capital Allocation Trends At China Isotope & Radiation (HKG:1763) Aren't Ideal
Oct 08Is Now An Opportune Moment To Examine China Isotope & Radiation Corporation (HKG:1763)?
Sep 05Returns On Capital At China Isotope & Radiation (HKG:1763) Paint A Concerning Picture
Jun 13When Should You Buy China Isotope & Radiation Corporation (HKG:1763)?
May 24China Isotope & Radiation (HKG:1763) Has A Pretty Healthy Balance Sheet
Apr 01Our Take On The Returns On Capital At China Isotope & Radiation (HKG:1763)
Mar 14The China Isotope & Radiation (HKG:1763) Share Price Has Gained 24% And Shareholders Are Hoping For More
Feb 04
Is Now The Time To Look At Buying China Isotope & Radiation Corporation (HKG:1763)?
Jan 09Will China Isotope & Radiation (HKG:1763) Multiply In Value Going Forward?
Dec 14China Isotope & Radiation Corporation's (HKG:1763) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Nov 23Financial Position Analysis
Short Term Liabilities: 1763's short term assets (CN¥8.2B) exceed its short term liabilities (CN¥4.3B).
Long Term Liabilities: 1763's short term assets (CN¥8.2B) exceed its long term liabilities (CN¥1.8B).
Debt to Equity History and Analysis
Debt Level: 1763 has more cash than its total debt.
Reducing Debt: 1763's debt to equity ratio has increased from 3.5% to 23% over the past 5 years.
Debt Coverage: 1763's debt is well covered by operating cash flow (40%).
Interest Coverage: 1763 earns more interest than it pays, so coverage of interest payments is not a concern.